Carbonylamino-benzimidazole derivatives as androgen receptor modulators

Details for Australian Patent Application No. 2003286757 (hide)

International Classifications

Event Publications

1 April 2004 Complete Application Filed

Priority application(s): 60/422,914 01.11.02 US

1 July 2004 Application Open to Public Inspection

Published as AU-B-2003286757

4 June 2009 Application Accepted

Published as AU-B-2003286757

1 October 2009 Standard Patent Sealed

21 January 2010 Amendment Made

The nature of the amendment is: Amend patentee name from Merck & Co., Inc. to Merck Sharp & Dohme Corp.

24 May 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.